We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
-6.32%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$1.49B
AUM Growth
-$858M
Cap. Flow
-$741M
Cap. Flow %
-49.73%
Top 10 Hldgs %
16.66%
Holding
333
New
9
Increased
17
Reduced
117
Closed
187

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$33M
2
MWV
MEADWESTVACO CORP
MWV
+$22.1M
3
VTRS icon
Viatris
VTRS
+$21.7M
4
TRV icon
Travelers Companies
TRV
+$21.5M
5
COO icon
Cooper Companies
COO
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.49%
2 Technology 16.08%
3 Financials 15.43%
4 Consumer Discretionary 10.59%
5 Consumer Staples 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
26
Mastercard
MA
$500B
$17.4M 1.17%
192,725
-163,505
-46% -$15.4M
AYI icon
27
Acuity Brands
AYI
$10.4B
$17.3M 1.16%
98,315
-14,302
-13% -$2.78M
BMY icon
28
Bristol-Myers Squibb
BMY
$135B
$17.1M 1.15%
288,320
+39,785
+16% +$2.52M
JNJ icon
29
Johnson & Johnson
JNJ
$614B
$17.1M 1.14%
182,686
-70,865
-28% -$6.86M
CME icon
30
CME Group
CME
$94.4B
$17M 1.14%
183,772
-4,155
-2% -$395K
LMT icon
31
Lockheed Martin
LMT
$136B
$16.7M 1.12%
80,402
-5,407
-6% -$1.1M
CVS icon
32
CVS Health
CVS
$133B
$16.7M 1.12%
172,724
-69,815
-29% -$7.34M
CHD icon
33
Church & Dwight Co
CHD
$24.4B
$16.6M 1.12%
396,576
-190,050
-32% -$8.15M
EFX icon
34
Equifax
EFX
$20.8B
$16.6M 1.11%
170,520
-42,420
-20% -$4.21M
APH icon
35
Amphenol
APH
$211B
$16.4M 1.1%
1,291,088
-803,680
-38% -$10.8M
TJX icon
36
TJX Companies
TJX
$174B
$16.3M 1.09%
456,758
-4,850
-1% -$170K
CIEN icon
37
Ciena
CIEN
$58.2B
$16.1M 1.08%
778,265
+1,840
+0.2% +$42.8K
BHC icon
38
Bausch Health
BHC
$2.41B
$16M 1.07%
89,552
-7,328
-8% -$1.71M
MPC icon
39
Marathon Petroleum
MPC
$91.3B
$15.9M 1.07%
343,600
-33,840
-9% -$1.74M
MNST icon
40
Monster Beverage
MNST
$92.1B
$15.9M 1.07%
706,512
-13,800
-2% -$323K
BAC icon
41
Bank of America
BAC
$440B
$15.7M 1.05%
1,004,561
-37,304
-4% -$628K
MRK icon
42
Merck
MRK
$316B
$15.6M 1.05%
331,008
-53,004
-14% -$2.82M
AMSG
43
DELISTED
Amsurg Corp
AMSG
$15.6M 1.05%
+200,719
New +$15.5M
PEP icon
44
PepsiCo
PEP
$190B
$15.3M 1.03%
162,569
-109,285
-40% -$10.4M
OPLN
45
Openlane
OPLN
$4.24B
$15.3M 1.03%
1,139,045
-64,901
-5% -$921K
ICLR icon
46
Icon
ICLR
$12.1B
$15.2M 1.02%
214,512
-14,705
-6% -$1.11M
DHR icon
47
Danaher
DHR
$137B
$15.2M 1.02%
265,109
-141,330
-35% -$8.35M
EOG icon
48
EOG Resources
EOG
$76.4B
$15.2M 1.02%
208,389
-43,360
-17% -$3.37M
USB icon
49
US Bancorp
USB
$100B
$15.1M 1.01%
368,591
-115,650
-24% -$5.01M
CBRE icon
50
CBRE Group
CBRE
$43.7B
$15M 1.01%
468,935
-104,175
-18% -$3.7M

Similar funds

Braun Stacey Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Braun Stacey Associates held 333 positions worth $1.49B, down 37% from $2.35B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Braun Stacey Associates withdrew a net $741M in Q3 2015, closing 187 positions and reducing 117 holdings. Its most notable exit was MEADWESTVACO CORP, an estimated $22.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

Against the trend, Braun Stacey Associates opened a new position in WestRock Company worth $14.3M.

  • Braun Stacey Associates's largest Q3 2015 buy was WestRock Company: 308,399 shares worth $14.3M.
  • Braun Stacey Associates added most to AbbVie in Q3 2015, an estimated $14.6M increase.
  • Braun Stacey Associates's biggest Q3 2015 reduction was Apple, cutting an estimated $33M.
  • Braun Stacey Associates fully exited MEADWESTVACO CORP in Q3 2015, selling an estimated $22.1M.
  • Braun Stacey Associates's ten largest holdings make up 17% of its $1.49B portfolio in Q3 2015.
  • Braun Stacey Associates opened 9 new positions and closed 187 in Q3 2015.
  • Braun Stacey Associates's portfolio value fell 37% quarter-over-quarter to $1.49B.

Based on Braun Stacey Associates's 13F filing for Q3 2015, filed 1 Dec 2015.